Network of three specific microRNAs influence type 2 diabetes through inducing insulin resistance in muscle cell

Maryam Honardoost1, Farid Keramati2, Ehsan Arefian3

  • 1Endocrine Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, Iran.

Insights

Three specific microRNAs (miRNAs) were found to induce insulin resistance in muscle cells. Upregulation of these miRNAs impaired glucose uptake, increasing type 2 diabetes risk.

Area of Science:

  • Molecular Biology
  • Endocrinology
  • Genetics

Background:

  • Insulin resistance is a key predictor of type 2 diabetes.
  • MicroRNAs (miRNAs) are implicated as regulators of insulin resistance.

Purpose of the Study:

  • To investigate the role of miR-135, miR-202, and miR-214 in insulin resistance.
  • To assess the impact of these miRNAs on glucose uptake in muscle cell lines.

Main Methods:

  • Transfection of C2C12 and L6 muscle cells with selected miRNAs.
  • Measurement of glucose uptake levels.
  • Luciferase assay to evaluate miRNA target gene expression.

Main Results:

  • miRNA transfection significantly altered glucose uptake compared to controls.
  • miR-135, miR-202, and miR-214 targeted and downregulated Rho-associated coiled-coil containing protein kinase 1 and serine/threonine kinase 2.
  • Vesicle-associated membrane protein 2 was not significantly affected.
  • Upregulated miRNAs led to poor insulin stimulation of glucose uptake and an insulin-resistant phenotype.

Conclusions:

  • The studied miRNAs (miR-135, miR-202, miR-214) play a role in inducing insulin resistance.
  • These miRNAs contribute to the development of an insulin-resistant phenotype in muscle cells.
  • This finding suggests a potential link between these miRNAs and type 2 diabetes susceptibility.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.0K
Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
735
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Cell Lines01:16

Cell Lines

A cell line is a population of cells grown in vitro that can be subcultured over several generations. Normal cells cease to divide after a certain number of cell divisions, a process known as replicative senescence. This number, called the Hayflick limit, was conceptualized by Leonard Hayflick in 1961 when he observed that fetal cells grown in culture could only divide 40-60 times. This limit is due to the shortening of the telomeres during each round of cell division, preventing cell division...
10.4K